Free Trial

Phreesia, Inc. (NYSE:PHR) Insider Yvonne Hui Sells 422 Shares

Phreesia logo with Medical background

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 422 shares of the stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $26.95, for a total value of $11,372.90. Following the completion of the transaction, the insider directly owned 30,281 shares in the company, valued at $816,072.95. This trade represents a 1.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Yvonne Hui also recently made the following trade(s):

  • On Tuesday, July 15th, Yvonne Hui sold 307 shares of Phreesia stock. The stock was sold at an average price of $27.27, for a total value of $8,371.89.
  • On Monday, July 7th, Yvonne Hui sold 571 shares of Phreesia stock. The stock was sold at an average price of $28.85, for a total value of $16,473.35.
  • On Tuesday, June 10th, Yvonne Hui sold 582 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $16,296.00.
  • On Monday, April 21st, Yvonne Hui sold 993 shares of Phreesia stock. The shares were sold at an average price of $23.04, for a total value of $22,878.72.

Phreesia Price Performance

NYSE PHR traded down $1.03 on Thursday, reaching $26.01. 659,101 shares of the stock traded hands, compared to its average volume of 453,402. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.02. The firm's fifty day simple moving average is $26.49 and its 200 day simple moving average is $26.39. The company has a market cap of $1.55 billion, a price-to-earnings ratio of -35.15 and a beta of 0.72.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.06. The business had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm's quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.05) EPS. As a group, research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on PHR. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. Canaccord Genuity Group dropped their price objective on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research note on Thursday, May 29th. KeyCorp upped their price target on shares of Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a report on Monday. Wall Street Zen raised Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Finally, DA Davidson dropped their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia has an average rating of "Buy" and an average target price of $32.27.

Check Out Our Latest Report on Phreesia

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently made changes to their positions in PHR. Johnson Financial Group Inc. grew its position in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. Quarry LP increased its holdings in shares of Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares in the last quarter. KBC Group NV bought a new stake in shares of Phreesia during the 1st quarter valued at $74,000. Farther Finance Advisors LLC boosted its stake in Phreesia by 9,375.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company's stock worth $86,000 after acquiring an additional 3,000 shares during the last quarter. Finally, CWM LLC raised its position in shares of Phreesia by 994.9% during the first quarter. CWM LLC now owns 4,040 shares of the company's stock worth $103,000 after purchasing an additional 3,671 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

About Phreesia

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

See Also

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Phreesia Right Now?

Before you consider Phreesia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.

While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines